Mulholland Michael D. 4
4 · CytoDyn Inc. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
MULHOLLAND MICHAEL D
CFO, Treasurer and Secretary
Transactions
- Exercise/Conversion
Common Stock
2020-12-22$0.90/sh+150,000$135,000→ 595,882 total - Exercise/Conversion
Common Stock
2020-12-22$1.09/sh+300,000$327,000→ 895,882 total - Sale
Common Stock
2020-12-22$7.00/sh−12,100$84,700→ 284,081 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2020-12-22+150,000→ 0 totalExercise: $0.90From: 2020-12-22Exp: 2025-06-30→ Common Stock (150,000 underlying) - Sale
Common Stock
2020-12-22$5.49/sh−245,704$1,349,849→ 750,178 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2020-12-22+161,801→ 0 totalExercise: $0.87From: 2020-12-22Exp: 2025-11-23→ Common Stock (161,801 underlying) - Exercise/Conversion
Common Stock
2020-12-22$0.87/sh+161,801$140,767→ 445,882 total - Sale
Common Stock
2020-12-22$6.61/sh−453,997$3,003,009→ 296,181 total - Exercise/Conversion
Common Stock
2020-12-22$1.40/sh+100,000$140,000→ 995,882 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2020-12-22+300,000→ 0 totalExercise: $1.09From: 2020-12-22Exp: 2026-06-01→ Common Stock (300,000 underlying) - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2020-12-22+100,000→ 0 totalExercise: $1.40From: 2020-12-22Exp: 2022-12-13→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The sale transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan the Reporting Person entered into on November 12, 2020. The plan provides for the periodic sales by the Reporting Person's broker without further action by the Reporting Person.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.03 to $5.98. The price above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $6.02 to $6.99. The price above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.